PCSK9抑制剂的拔河：依从性、不良事件和ldl -胆固醇目标

{"title":"PCSK9抑制剂的拔河：依从性、不良事件和ldl -胆固醇目标","authors":"Francesco Sbrana, Beatrice Dal Pino","doi":"10.1016/j.artere.2025.500771","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100263,"journal":{"name":"Clínica e Investigación en Arteriosclerosis (English Edition)","volume":"37 2","pages":"Article 500771"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PCSK9 inhibitors tug of war: Compliance, adverse events and LDL-cholesterol target\",\"authors\":\"Francesco Sbrana, Beatrice Dal Pino\",\"doi\":\"10.1016/j.artere.2025.500771\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100263,\"journal\":{\"name\":\"Clínica e Investigación en Arteriosclerosis (English Edition)\",\"volume\":\"37 2\",\"pages\":\"Article 500771\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clínica e Investigación en Arteriosclerosis (English Edition)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2529912325000518\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clínica e Investigación en Arteriosclerosis (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2529912325000518","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}